Register now for MedTech M&A, Regulatory Quality & Due Diligence | A Virtual Conference | October 23–24, 2019With 253 deals occurring during this year’s second quarter, the medical device industry experienced an 11% increase in deal activity versus its four-quarter average, according to a recent report released by analyst firm GlobalData. Venture financing accounted for nearly 75% of the deals (189 transactions), followed by mergers and acquisitions at 20% and private equity deals at 5% (13 deals). M&A led the pack when looking at deal value, which was estimated at about $13.6 billion. Venture capital financing was at $2 billion, followed by private equity at $211 million.
When looking at deal size, nearly 84% of the overall deal value was thanks to the top five transactions of the quarter, the largest of which was 3M’s acquisition of Acelity in May. The second-largest deal was Dassault Systemes’ acquisition of Medidata Solutions for $5.8 billion, followed by Boston Scientific taking VertiFlex for $465 million.